About / Our Standard
A standard we can evidence, not a story we can tell.
ELLIVON BIOSCIENCES was built around a narrow and deliberate remit: publish accurate peptide science, describe quality practice honestly, and route every clinical question to a qualified professional. We do not sell to the public, and we do not make treatment claims.
Brand story
Founded on restraint.
Peptide science is genuinely promising and genuinely early. Most of the harm in this category comes not from the molecules but from the way they are marketed — overstated, under-documented, and sold directly to people who have had no clinical assessment.We took the opposite position from the beginning. Ellivon exists to make the science legible and to make the professional pathway obvious. Science. Precision. Potential.
Our standard
Six commitments we hold ourselves to.
- 01
Responsible science
We publish neutral reference information and refuse to describe unproven compounds as safe or effective. Where evidence is thin, we say so in the same sentence as the science.
- 02
Sourcing transparency
Supplier assessment covers documented manufacturing controls, analytical methods and the ability to trace material back to a defined batch. Where a supply route cannot be documented, it does not appear here.
- 03
Testing & COA placeholders
Certificates of analysis will be published against batch identifiers as they are issued. We do not display third-party marks, certifications or approvals that we do not hold.
- 04
Batch & lot traceability
Every reference batch is designed to carry a lot identifier that links physical material to its analytical documentation and handling record.
- 05
Cold chain
Temperature-sensitive material requires validated packaging, monitored transport and defined excursion handling. We describe these principles openly rather than making guarantees we cannot evidence.
- 06
Medical oversight
Clinical interpretation is not our role. Enquiries with a clinical dimension are directed to registered healthcare professionals and licensed pharmacy channels.
South Africa — compliance notice
SAHPRA has publicly warned about unregistered peptide products being marketed to the South African public. In general, products intended to diagnose, treat, or otherwise alter bodily functions require registration or authorisation before they may lawfully be sold. ELLIVON BIOSCIENCES publishes reference information only and directs all clinical questions to registered healthcare professionals and licensed pharmacy channels.